Abstract
The generation of genetically altered mice for research is invaluable for investigations into the underlying mechanisms of common complex diseases such as cancer as well as for therapeutic studies. The correct identification of the genotype of each mouse is therefore essential. Genotyping is routinely performed by using blood, tail or ear tissue; however, this can cause pain or discomfort to the animal and nor is amenable to scale up for high-throughput sampling and analyses. Genotyping from saliva, hair and rectal cells is less invasive, but still requires the restraint of the animal. In contrast, collection of stool samples for DNA isolation is non-invasive as well as repeatable and time efficient, with recent studies showing it to be as accurate as the alternative methods. Fecal DNA genotyping therefore provides an attractive technique for non-invasive genotyping. This feature article examines and synthesizes the recent advances in fecal genotyping with a view to mouse models for nutrigenomics cancer chemoprevention studies specifically, and personalized medicine more broadly.
Keywords: Cancer, feces, genotyping, non-invasive, novel diagnostic platforms, personalized medicine, transgenic mice
Current Pharmacogenomics and Personalized Medicine
Title:Fecal DNA Genotyping: A Non-invasive Approach to Characterize Mouse Models for Nutrigenomics Cancer Chemoprevention Studies
Volume: 11 Issue: 1
Author(s): Erin L. Symonds
Affiliation:
Keywords: Cancer, feces, genotyping, non-invasive, novel diagnostic platforms, personalized medicine, transgenic mice
Abstract: The generation of genetically altered mice for research is invaluable for investigations into the underlying mechanisms of common complex diseases such as cancer as well as for therapeutic studies. The correct identification of the genotype of each mouse is therefore essential. Genotyping is routinely performed by using blood, tail or ear tissue; however, this can cause pain or discomfort to the animal and nor is amenable to scale up for high-throughput sampling and analyses. Genotyping from saliva, hair and rectal cells is less invasive, but still requires the restraint of the animal. In contrast, collection of stool samples for DNA isolation is non-invasive as well as repeatable and time efficient, with recent studies showing it to be as accurate as the alternative methods. Fecal DNA genotyping therefore provides an attractive technique for non-invasive genotyping. This feature article examines and synthesizes the recent advances in fecal genotyping with a view to mouse models for nutrigenomics cancer chemoprevention studies specifically, and personalized medicine more broadly.
Export Options
About this article
Cite this article as:
L. Symonds Erin, Fecal DNA Genotyping: A Non-invasive Approach to Characterize Mouse Models for Nutrigenomics Cancer Chemoprevention Studies, Current Pharmacogenomics and Personalized Medicine 2013; 11 (1) . https://dx.doi.org/10.2174/1875692111311010004
DOI https://dx.doi.org/10.2174/1875692111311010004 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diagnosis in PANDAS: An Update
Current Psychiatry Research and Reviews A Model for Heterogeneous Brain Tumor Cells that Cause Dizziness
Current Cancer Therapy Reviews Functional Neuroproteomics: An Imperative Approach for Unravelling Protein Implicated Complexities of Brain
CNS & Neurological Disorders - Drug Targets Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Current Diabetes Reviews Preliminary Pharmacological Screening of Some Thiosemicarbazide, s-triazole, and Thiadiazole Derivatives
CNS & Neurological Disorders - Drug Targets Detection of Catecholamine Neurotransmitters by Nanostructured SnO<sub>2</sub>-Based Electrochemical Sensors: A Review of Recent Progress
Mini-Reviews in Organic Chemistry The Effects of Locus Coeruleus and Norepinephrine in Methamphetamine Toxicity
Current Neuropharmacology A Critical Review of Rating Scales in the Assessment of Movement Disorders in Schizophrenia
Current Drug Targets Redox Modification of Platelet Glycoproteins
Current Drug Targets The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets Neuropsychiatric and Cognitive Symptoms in Spinocerebellar Ataxia: Relationship to Neuropathological Differences
Current Psychiatry Reviews Taste and Hypertension in Humans: Targeting Cardiovascular Disease
Current Pharmaceutical Design Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Regulation of Apoptosis and Activity of the Osteoclast
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Current Molecular Pharmacology Advances in Mucomodulator Therapy for Treatment of Excess Airway Mucus in Patients with Asthma, Chronic Obstructive Pulmonary Disease and Cystic Fibrosis
Recent Patents on Materials Science On the Design of Broad Based Screening Assays to Identify Potential Pharmacological Chaperones of Protein Misfolding Diseases
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Macrophage Migration Inhibitory Factor (MIF) and Its Receptors – Interactions and Suitability as Biomarkers)
Mini-Reviews in Medicinal Chemistry Recent US Patents on Extracellular Matrix in Tissue Engineering and Regenerative Medicine
Recent Patents on Regenerative Medicine Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery
Current Topics in Medicinal Chemistry